Company Monitoring Page for Genentech

latest headlines for company on cafepharma

Curis Earns $8 Million Milestone As NDA Accepted By FDA
Seeking Alpha
Thu, 11/10/11 - 01:08 pm
Tags:
Curis, milestone payments, FDA, basal cell carcinoma, Genentech, vismodegib
Micromet Unveils Another Fast Route To Market, Marks Pfizer As Lead Competitor
Seeking Alpha
Sun, 10/16/11 - 07:05 pm
Tags:
Micromet, Pfizer, blinatumomab, acute lymphoblastic leukemia, leukemia, Bmab, SAR3419, Sanofi, inotuzumab, Genentech, Seattle Genetics
Doctors Grow Wary of Avastin for Eye Treatment
NY Times, NY
Wed, 10/5/11 - 10:55 am
Tags:
Genentech, Avastin, Lucentis
New label on Genentech's Avastin warns of infertility
Bizjournals.com
Wed, 10/5/11 - 10:50 am
Tags:
Avastin, Infertility, warnings, Genentech
Insurer Won’t Pay For Avastin Breast Cancer Use
Pharmalot
Mon, 10/3/11 - 11:03 am
Tags:
breast cancer, Avastin, insurance, Genentech
Off-Label Avastin Use, Medicare And Saving Money
Pharmalot
Wed, 09/7/11 - 09:54 am
Tags:
Medicare, off-label, Avastin, Roche, Genentech, age-related macular degeneration
Off-Label Avastin Injections Linked To Blindness
Pharmalot
Wed, 08/31/11 - 09:31 am
Tags:
off-label, blindness, Avastin, Genentech, Roche
Galapagos gains third extension of Genentech deal in $35M pact
Fierce Biotech
Thu, 08/18/11 - 02:17 pm
Tags:
Genentech, Galapagos, Argenta
Array BioPharma lands Genentech drug-development deal
Bizjournals.com
Tue, 08/9/11 - 10:07 am
Tags:
drug development, Array Biopharma, Genentech
Genentech pitches Avastin compromise to FDA
Fierce Pharma
Mon, 08/8/11 - 12:39 pm
Tags:
FDA, breast cancer, Avastin, Genentech
PDL climbs 8% on patent case ruling
Marketwatch
Mon, 07/11/11 - 12:33 pm
Tags:
PDL Biopharma, patents, Roche, Genentech, Avastin, Herceptin, Lucentis, Xolair
Genentech, Once Known For Innovation, Is Pursuing A Nexium Strategy With Lucentis
Forbes
Sat, 04/30/11 - 10:07 am
Tags:
Genentech, Lucentis, macular degeneration
Roche's Genentech Sues Novartis Unit Claiming Infringement of Valcyte Drug
Bloomberg
Thu, 04/21/11 - 09:23 am
Tags:
Genentech, Novartis, Valcyte, generics, patents, AIDS
FDA approves Genentech vasculitis treatment
Bizjournals.com
Wed, 04/20/11 - 12:04 pm
Tags:
FDA, Genentech, vasculitis, Rituxan
10 promising late-stage cancer drugs
Fierce Biotech
Tue, 04/5/11 - 10:47 pm
Tags:
cancer, Carfilzomib, crizotinib, vismodegib, Oncovex, PLX4032, Ponatinib, SGN-35, tivozanib, T-DM1, cabozantinib, ONYX Pharmaceuticals, Pfizer, Genentech, Curis, Amgen, Plexxikon, Seattle Genetics, Ariad Pharmaceuticals, Aveo Pharmaceutical, Exelixis, Roche
Pfizer, Genentech and APP initiate recalls
Fierce Pharma
Mon, 03/28/11 - 11:45 am
Tags:
recalls, Pfizer, Genentech, APP
Which Sales Reps Rank Highest With Oncologists?
Pharmalot
Tue, 02/22/11 - 10:36 am
Tags:
drug reps, oncologists, Roche, Genentech, Novartis
Genentech's Lucentis does well in study of diabetic eye condition Read more: Genentech's Lucentis does well in study of diabetic eye condition
bizjournals.com
Sat, 02/12/11 - 12:21 pm
Tags:
Lucentis, Genentech, diabetic macular edema, diabetes
Genentech cites chemo comparisons in Avastin appeal
Fierce Pharma
Wed, 01/19/11 - 11:16 am
Tags:
Avastin, Roche, Genentech, FDA, breast cancer
Roche, Avastin And An Influential Cancer Doc Panel
Pharmalot
Tue, 01/11/11 - 02:41 pm
Tags:
Avastin, Roche, Genentech, FDA, breast cancer

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.